View of High Risk of Infection During Triple Therapy with First- Generation Protease Inhibitors: A Nationwide Cohort Study

Return to Article Details High Risk of Infection During Triple Therapy with First- Generation Protease Inhibitors: A Nationwide Cohort Study Download Download PDF